This article explores the role scientists at the National Cancer Institute (NCI), a US federal science agency, played in researching and testing vaccines against the human papillomavirus (HPV). Drawing upon archival sources and oral history interview data, I challenge narratives that attribute the design of HPV vaccines to profit motive. Instead, I show that the researchers who developed the technology attempted to construct ethical approaches to vaccine development based on the values that emerged from their situated environments of technological, organizational, and institutional constraint. I argue that interpretations of “translational research” native to the NCI influenced these researchers’ efforts to design and test HPV vaccines. The organizational culture of translational research emerging in the NCI positioned intramural research as a countervailing and supplementary force to market-oriented translational research and development. Over time, NCI researchers’ conceptions of the Institute’s role allowed them to develop understandings of ethical HPV vaccine research as oriented toward addressing cervical cancer health disparities, especially in developing nations. NCI scientists’ understanding of their role in serving the public good through continued HPV vaccine innovation reflects the material and political economic environment they faced at different historical junctures that constrained the possibilities for innovation and ethical action.
...More
Article
Beth Greenhough;
Emma Roe;
(July 2018)
Exploring the Role of Animal Technologists in Implementing the 3Rs: An Ethnographic Investigation of the UK University Sector
(/isis/citation/CBB661318783/)
Article
Carmen McLeod;
Sarah Hartley;
(July 2018)
Responsibility and Laboratory Animal Research Governance
(/isis/citation/CBB564349730/)
Article
Mattia Andreoletti;
David Teira;
(2019)
Rules versus Standards: What Are the Costs of Epistemic Norms in Drug Regulation?
(/isis/citation/CBB881753075/)
Article
Robert G. W. Kirk;
(July 2018)
Recovering The Principles of Humane Experimental Technique: The 3Rs and the Human Essence of Animal Research
(/isis/citation/CBB661013428/)
Article
Ashlyn Jaeger;
(2019)
(Re)Producing Cyborgs: Biomedicalizing Abortion through the Congressional Debate over Fetal Pain
(/isis/citation/CBB770211028/)
Article
Akos Kokai;
Alastair Iles;
Christine Meisner Rosen;
(November 2021)
Green Design Tools: Building Values and Politics into Material Choices
(/isis/citation/CBB745455255/)
Article
Allison Loconto;
Scott Prudham;
Steven Wolf;
(2024)
Environmental governance through metrics: guest introduction
(/isis/citation/CBB894684908/)
Article
Jenny Andersson;
Erik Westholm;
(2019)
Closing the Future: Environmental Research and the Management of Conflicting Future Value Orders
(/isis/citation/CBB589179620/)
Article
Emmanuel Henry;
(September 2021)
Governing Occupational Exposure Using Thresholds: A Policy Biased Toward Industry
(/isis/citation/CBB676852860/)
Article
Kris Hartley;
(November 2021)
Public Trust and Political Legitimacy in the Smart City: A Reckoning for Technocracy
(/isis/citation/CBB172268665/)
Article
Natasha D. Schüll;
(March 2022)
Afterword: Shifting the Terms of the Debate
(/isis/citation/CBB889022961/)
Article
Emmanuel Henry;
Valentin Thomas;
Sara Angeli Aguiton;
Marc-Olivier Déplaude;
Nathalie Jas;
(September 2021)
Introduction: Beyond the Production of Ignorance: The Pervasiveness of Industry Influence through the Tools of Chemical Regulation
(/isis/citation/CBB736985993/)
Article
Allain J. Barnett;
Melanie G. Wiber;
(2019)
What Scientists Say about the Changing Risk Calculation in the Marine Environment under the Harper Government of Canada (2006-2015)
(/isis/citation/CBB359628559/)
Article
Alexander Rushforth;
Thomas Franssen;
Sarah de Rijcke;
(2019)
Portfolios of Worth: Capitalizing on Basic and Clinical Problems in Biomedical Research Groups
(/isis/citation/CBB805796865/)
Article
Cook, Brian R.;
Kesby, Mike;
Fazey, Ioan;
Spray, Chris;
(October 2013)
The persistence of ‘normal’ catchment management despite the participatory turn: Exploring the power effects of competing frames of reference
(/isis/citation/CBB350967664/)
Article
Brian Salter;
(January 2022)
Markets, Cultures, and the Politics of Value: The Case of Assisted Reproductive Technology
(/isis/citation/CBB380652953/)
Article
David Moats;
Liz McFall;
(2019)
In Search of a Problem: Mapping Controversies over NHS (England) Patient Data with Digital Tools
(/isis/citation/CBB339833803/)
Book
Wailoo, Keith;
Livingston, Julie;
Epstein, Steven G.;
(2010)
Three Shots at Prevention: The HPV Vaccine and the Politics of Medicine's Simple Solutions
(/isis/citation/CBB001031343/)
Article
Oscar Javier Maldonado Castañeda;
(2021)
Connective data: Markov chain models and the datafication of cervical cancer and HPV vaccination in Colombia
(/isis/citation/CBB001445188/)
Book
Hannaway, Caroline;
(2008)
Biomedicine in the Twentieth Century: Practices, Policies, and Politics
(/isis/citation/CBB000850366/)
Be the first to comment!